- Patients
- Clinical Research
- Clinical trials
- LOXO-FG3
2024-07-25T03:06:22.461Z
LOXO-FG3
LOXO-FG3
Solid tumors
An Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Advanced Solid Tumour Malignancies with FGFR3 Alterations.
An Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Advanced Solid Tumour Malignancies with FGFR3 Alterations.
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Solid tumours
Study Phase
III
Trial registration
Number: NCT05614739
GenesisCare Location(s)
GenesisCare North Shore
GenesisCare North Shore
:::
Principal Investigator(s)